Kara L. Lynch

Researcher Next ID · RN-044444

Researcher · Medicine

San Francisco, Argentina

Accepting doctoral researchersFunding unknown

Research interests

Medicine

Pharmacology, Toxicology and Pharmaceutics

Physics and Astronomy

Forensic Toxicology and Drug Analysis

SARS-CoV-2 and COVID-19 Research

COVID-19 Clinical Research Studies

Opioid Use Disorder Treatment

Particle physics theoretical and experimental studies

Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2
Nature Immunology · 2024 · https://doi.org/10.1038/s41590-023-01724-6
A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection
Nature · 2023 · https://doi.org/10.1038/s41586-023-06331-x
Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
Science Translational Medicine · 2021 · https://doi.org/10.1126/scitranslmed.abh2624
Test performance evaluation of SARS-CoV-2 serological assays
medRxiv · 2020 · https://doi.org/10.1101/2020.04.25.20074856
Evaluation of SARS-CoV-2 serology assays reveals a range of test performance
Nature Biotechnology · 2020 · https://doi.org/10.1038/s41587-020-0659-0
Magnitude and Kinetics of Anti–Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity
Clinical Infectious Diseases · 2020 · https://doi.org/10.1093/cid/ciaa979
Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review
Neuropharmacology · 2017 · https://doi.org/10.1016/j.neuropharm.2017.10.016
Role of liquid chromatography–high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology
Clinical Toxicology · 2012 · https://doi.org/10.3109/15563650.2012.713108

No projects listed.